OSTX Stock Analysis: Buy, Sell, or Hold?
OSTX - OS Therapies Incorporated
$1.60
0.05 (3.23%)
▲
5d:
+6.67%
30d:
-0.62%
90d:
-3.61%
BUY
HIGH Confidence
Analysis Updated: Aug 3, 2026 12:00 AM ET
Earnings: Aug 17, 2026
12d
Get Alerted When OSTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: OSTX shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: OSTX shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$2.17
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$1.35
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 4.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: OSTX is currently trading at $1.60, which is considered fair relative to its 30-day fair value range of $1.46 to $1.80. The stock's valuation (Forward PE: 4.3) is in line with its historical norms (4.3). At these levels, the market is pricing in 0.3% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, OSTX is in a uptrend. The price is approaching resistance at $1.62. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.2% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $8.92 (+475.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, OSTX is in a uptrend. The price is approaching resistance at $1.62. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.2% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $8.92 (+475.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.46 -
$1.80
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
78.1%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.2%)
- BULLISH: Trading 475.4% below Wall St target ($8.92)
- NEUTRAL: Market pricing in 0.3% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$1.46 -
$1.80
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.47
Resistance Level
$1.62
Current Trend
Uptrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
4.31
Wall Street Target
$8.92
(+475.4%)
Valuation Premium vs History
+0.3% premium
PE vs Historical
4.3 vs 4.3
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.3%
(market-implied from PE analysis)
1-Year Target
$1.55
(+0%)
2-Year Target
$1.56
(+1%)
3-Year Target
$1.56
(+1%)
3-Yr Target (if PE normalizes)
(PE: 4→4)
PE COMPRESSION
$1.56
(+1%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: August 04, 2026 9:53 AM ET
Data refreshes hourly during market hours. Next update: 10:53 AM
Data refreshes hourly during market hours. Next update: 10:53 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OSTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$87 | 56 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$196 | 46 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$108 | 60 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$86 | 47 HOLD |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$23 | 51 HOLD |
